A recent publication showed that OncoDNA provided information on available treatments in 92% of patients with advanced solid cancer. However, each cancer is different and it may also be that no alternative is found. The usefulness of the test will depend on your type of cancer, its severity, which treatments you have already received, and many other factors. Feel free to ask your oncologist to contact us to assess the possible benefits regarding your case.
After ordering the test that you need via the OncoSHARE web platform, your oncologist will receive a kit that he/she will use to send us your sample (tumour tissue specimen or/and blood sample). You will be asked to settle your invoice by credit card or bank transfer. Once we receive your payment and your sample, we will perform the analysis in our certified laboratory. Your oncologist will be notified as soon as the results are available (7 to 10 working days), so that he/she can check the report with our therapeutic recommendations.
We do not advise to use our tests for early-stage cancers (stage 1 or 2), as well as for liquid tumors (i.e. leukemia, myeloma, etc.). In addition, we do not analyse paediatric tumours (patients aged ≤ 18 years), except for glioblastoma cases. In summary, we recommend using our solutions for stage 3 or 4 solid cancers in adults (except for glioblastoma patients).
We cannot guarantee that all suggested treatments will be available and/or reimbursed in your country. In some cases, if a treatment is not officially available or reimbursed, you could enroll in a clinical trial. Do not hesitate to ask your oncologist about the best options.
Our tests are designed to provide your oncologist with the most comprehensive information to make the best choice of treatment. However, cancer is a complex disease that evolves over time, and therefore it is very complex to predict the efficacy of a treatment. What we are doing is to provide you with the best possibilities of treatment based on scientific knowledge.
Yes, our solutions may give information to the oncologist regarding your response to immunotherapy. We test a wide range of markers of sensitivity to immunotherapy and provide an immunogram to better visualise the results. However, we may also recommend other treatment options such as hormonal therapy, chemotherapy or targeted therapy.
If your question is not included in the list above or you would like more information about our solutions, please contact us at firstname.lastname@example.org. Our Patient and Scientific Support teams are available to answer your questions from Monday to Friday. You can also reach us through the chat (icon at the bottom right corner of current window).